Evidence map›Paper›PMID 39518208›Full record

ReviewPolymers2024

Morphology Control of Polymer-Inorganic Hybrid Nanomaterials Prepared in Miniemulsion: From Solid Particles to Capsules.

Olaia Álvarez-Bermúdez, Inés Adam-Cervera, Katharina Landfester, Rafael Muñoz-Espí

Abstract readReview
In one paragraph

Review in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Advances in Drug Delivery Systems for Boswellic Acids fromInternational journal of molecular sciences · 2026
    Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Olaia Álvarez-BermúdezInstitute of Materials Science (ICMUV), Universitat de València, c/Catedràtic José Beltrán 2, 46980 Paterna, Spain.
Inés Adam-CerveraInstitute of Materials Science (ICMUV), Universitat de València, c/Catedràtic José Beltrán 2, 46980 Paterna, Spain.ORCID 0000-0002-1840-2353
Katharina LandfesterMax Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany.ORCID 0000-0001-9591-4638
Rafael Muñoz-EspíInstitute of Materials Science (ICMUV), Universitat de València, c/Catedràtic José Beltrán 2, 46980 Paterna, Spain.ORCID 0000-0002-8146-2332

Funding

Max Planck Society Max Planck Partner Group ProgramSpanish Ministry of Science and Innovation / Generalitat Valenciana MFA/2022/064
6 · The paper itself

Abstract

The preparation of so-called hybrid nanomaterials has been widely developed in terms of functional and morphological complexity. However, the specific control of the arrangement of organic and inorganic species, which determines the properties of the final material, still remains a challenge. This article offers a review of the strategies that have been used for the preparation of polymer-inorganic hybrid nanoparticles and nanocapsules via processes involving miniemulsions. Different polymer-inorganic nanostructures are classified into four main groups according to the sequential order followed between the synthesis of the polymer and the inorganic species, and the presence or not of their counterpart precursors. The minimization of the energy of the system governs the self-assembly of the different material components and can be addressed by the miniemulsion formulation to reduce the interfacial tensions between the phases involved. The state of the art in the preparation of hybrid nanoparticles is reviewed, offering insight into the structural possibilities allowed by miniemulsion as a versatile synthetic technique.

Indexed as

hybridminiemulsionmorphology controlnanocapsulenanoparticleorganic–inorganic

Identifiers

PMID39518208
PMCPMC11548365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.